Cambridge, United Kingdom

Alexander Robert Duncan

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 19.6

ph-index = 4

Forward Citations = 460(Granted Patents)


Location History:

  • Little Shelford, GB (2005 - 2010)
  • Carton, GB (2011)
  • Cambridge, GB (2009 - 2015)

Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Alexander Robert Duncan - Innovating Human Antibodies in Cambridge

Introduction:

Alexander Robert Duncan is a pioneering inventor based in Cambridge, GB, renowned for his groundbreaking work in developing human antibodies. With an impressive portfolio of 7 patents to his name, Duncan is a leading figure in the field of biochemistry and pharmaceutical innovation.

Latest Patents:

Duncan's recent patents focus on human antibodies that bind the P40 subunit of human IL-12 and methods for utilizing them. These antibodies, particularly recombinant human antibodies, exhibit high affinity for human interleukin-12 (hIL-12) and effectively neutralize its activity both in vitro and in vivo. They hold significant potential for detecting hIL-12 and inhibiting its activity in individuals suffering from disorders where hIL-12 plays a detrimental role. The invention also encompasses nucleic acids, vectors, and host cells required for expressing these recombinant human antibodies.

Career Highlights:

Throughout his illustrious career, Alexander Robert Duncan has contributed significantly to the field of biomedical research. Notably, he has made significant strides during his tenure at renowned companies such as Abbott Gmbh & Co. KG and Abbott Laboratories Corporation. His innovative approaches and groundbreaking discoveries have cemented his reputation as a forward-thinking inventor in the pharmaceutical industry.

Collaborations:

Duncan has collaborated with esteemed professionals in the field, including Jochen G Salfeld and Michael Roguska. Together, they have pushed the boundaries of antibody research and made significant advancements in developing novel therapeutic solutions.

Conclusion:

In conclusion, Alexander Robert Duncan stands as a trailblazer in the realm of biomedical innovation, with his work on human antibodies showcasing his dedication to advancing healthcare solutions. His patents and collaborations underscore his commitment to pioneering cutting-edge technologies that have the potential to revolutionize the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…